In infants 9 months of age or older, in children, and in adolescents with Sickle Cell Disease, offer treatment with hydroxyurea regardless of clinical severity.
SNOMED_CT Problem=129825007 (PB0041); SNOMED_CT Cat-Tar=4090322004 (CG0003, TG0073)
Hydroxyurea therapy
-
medication coordination/ordering